Nicole Villeneuve

USPTO Granted Patents = 15 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 80(Granted Patents)

Location History:

Rueil Malamaison, FR (2001)
Rueil Malmaison, FR (1991 - 2017)

Company Filing History:

Les Laboratoires Servier

Les Laboratories Servier

patents

where one patent can have more than one assignee

Years Active: 1991-2017

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9809553 - Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them (2017-11-07),

2. 8853198 - Agents for treating disorders involving modulation of ryanodine receptors (2014-10-07),

3. 8076325 - 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them (2011-12-13),

4. 6908922 - Linear cyclic ureas (2005-06-21),

5. 6903103 - Linear cyclic ureas (2005-06-07),

6. 6780868 - Linear cyclic ureas (2004-08-24),

7. 6696469 - Cyclobutenedione compounds (2004-02-24),

8. 6566364 - Linear or cyclic ureas (2003-05-20),

9. 6323217 - Piperidine-4 sulphonamide compounds (2001-11-27),

10. 5565457 - Substituted sulfonamides (1996-10-15),

11. 5298503 - N-(isoquinolin-5-ylsulphonyl) azacycloalkanes (1994-03-29),

12. 5296482 - (Benzocycloalkyl) alkylamines (1994-03-22),

13. 5283246 - Trimetazidine compounds (1994-02-01),

14. 5208243 - 5-isoquinolinesulfonamides (1993-05-04),

15. 4999372 - New aminochromanol compounds (1991-03-12),

Title: Discovering the Innovations of Nicole Villeneuve

Introduction

Nicole Villeneuve is an esteemed inventor based in Rueil Malmaison, France, known for her significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 15 patents, she has established herself as a prominent figure in the development of pharmaceutical compounds aimed at addressing various medical conditions.

Latest Patents

Nicole's latest innovations include advancements in isoquinoline compounds and their preparation processes, as well as pharmaceutical compositions created from these compounds. One of her patented compounds is particularly notable for its potential in treating or preventing pathologies resulting from the activation of the RhoA/ROCK pathway and the phosphorylation of myosin light chain. Additionally, she has developed agents targeting disorders related to ryanodine receptors, with a focus on 1,4-benzothiazepine derivatives. These compounds are designed to manage conditions associated with ryanodine receptors, which play a crucial role in regulating calcium channel functioning in cells, particularly in cardiac, musculoskeletal, and central nervous system disorders.

Career Highlights

Throughout her career, Nicole has collaborated with esteemed organizations such as Adir Et Compagnie and Les Laboratoires Servier. Her work has consistently reflected her commitment to advancing pharmaceutical science, contributing innovative solutions for complex health issues.

Collaborations

Nicole Villeneuve has worked alongside talented professionals, including Jean-Paul Vilaine and Jean-Louis Peglion. These collaborations have facilitated her growth as an inventor and have significantly impacted her contributions to biomedical research.

Conclusion

Nicole Villeneuve stands out as a trailblazer in the field of medicinal innovations. Her extensive patent portfolio demonstrates her commitment to advancing medical treatments through the development of pioneering compounds and processes. Her work not only enriches the pharmaceutical landscape but also highlights the enduring impact of women inventors in science and technology.

This text is generated by artificial intelligence and may not be accurate.